Skip to content

Medical-device intelligence

OIU: Test, Epithelial Ovarian Tumor Associated Antigen (He4)

FDA product code OIU: Test, Epithelial Ovarian Tumor Associated Antigen (He4). View classification details, related manufacturers, 510(k) clearances, and recall records.

FDA classification ↗

Classification details

Product code
OIU
FDA device name
Test, Epithelial Ovarian Tumor Associated Antigen (He4)
Device class
2
Regulation number
866.6010
Medical specialty
Immunology
Review panel
IM

FDA definition

An enzyme immunometric assay for the quantitative determination of HE4 in human serum. The assay is to be used as an aid in monitoring recurrence or progressive disease in patients with epithelial ovarian cancer. Serial testing for patient HE4 assay values should be used in conjunction with other clinical methods used for monitoring ovarian cancer. It is not intended to estimate or assess the risk of disease outcomes of patients.
Explore immunology records →
A product code groups records by FDA classification. It does not establish identical intended uses, commercial availability, or comparative device safety.

Record activity in this scope

5 clearance records and 0 recall records in the covered releases, across 2 source company names and 1 product codes. Dated history runs from Jun 9, 2008 to Nov 24, 2015.

Monthly counts through October 2026
Month510(k) decisionsRecall initiations
October 202500
November 202500
December 202500
January 202600
February 202600
March 202600
April 202600
May 202600
June 202600
July 202600
August 202600
September 202600
October 202600

Product codes represented

Code and FDA device nameClearancesRecalls
OIU · Test, Epithelial Ovarian Tumor Associated Antigen (He4)50

All-history totals use the covered releases; monthly counts stop at the last calendar month covered by both sources. Clearances use decision dates; recalls use initiation dates. 0 records lack the required date and are excluded from monthly counts. These are records, not product launches, market share, incidence rates, or comparative safety. Feed filters below do not change this overview.

Clearances and recall records

5 matching records
Device / recordCompany in FDA recordSourceSource date
Lumipulse G HE4 Immunoreaction Cartridges, Lumipulse G HE4 CalibratorsK151378 · OIUFujirebio Diagnostics,Inc.510(k)Nov 24, 2015FDA decision date
ELECSYS HE4, ELECSYS HE4 CALSET, ELECSYS PRECICONTROL HE4, ELECSYS HE4 CALCHECK 5K112624 · OIURoche Diagnostics510(k)Sep 10, 2012FDA decision date
FUJIREBIO DIAGNOSTICS TUMOR MARKER CONTROLK103676 · OIUFujirebio Diagnostics,Inc.510(k)Jul 19, 2011FDA decision date
ARCHITECT HE4, ARCHITECT HE4 CALIBRATORS AND ARCHITECT HE4 CONTROLS, MODELS 2, 2P54, 2P54-01, 2P54-10 SP54-01,K093957 · OIUFujirebio Diagnostics,Inc.510(k)Mar 18, 2010FDA decision date
HE4 EIA, MODEL: 404-10 USK072939 · OIUFujirebio Diagnostics,Inc.510(k)Jun 9, 2008FDA decision date

Manufacturers in these records

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 21, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 21, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 21, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗